21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
01.16 - Cultivation of fiber plants
01.28 - Cultivation of spice, aromatic plants and plants used for pharmaceuticals
01.30 - Plant propagation
01.64 - Crop and animal production, hunting and related service activities
10.89 - Production of other food products, not elsewhere classified
20.53 - Manufacture of chemicals and chemical products
21.10 - Manufacture of basic pharmaceutical products
72.11 - Scientific research and development activities
72.19 - Scientific research and development activities
2022 | 2023 | ||
---|---|---|---|
K PLN | K PLN | % | |
Gross profit (loss) | -87,4 | 0 | 100 |
EBITDA | -87,5 | 0 | 100 |
Short time liabilities | 144,8 | 351 | 142,4 |
Equity capital | -121,2 | -270,4 | -123 |
Operating profit (EBIT) | -87,5 | 0 | 100 |
Assets | 23,6 | 80,7 | 242,4 |
Net profit (loss) | -87,4 | 0 | 100 |
Cash | 0,1 | 6,8 | 5037,2 |
Net income from sale | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 144,8 | 351 | 142,4 |
Working assets | 23,6 | 42,2 | 78,9 |
Depreciation | 0 | 0 | 0 |
% | % | p.p. | |
Profitability of capital | 72,1 | 0 | -72,1 |
Equity capital to total assets | -514,5 | -335,1 | 179,4 |
Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 0.1627219319343567 | 0.12010283768177032 | -0,1 |
Net dept to EBITDA | -1.5841491222381592 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane